Trial Profile
Association of Dronedarone therapy with a risk of myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2018
Price :
$35
*
At a glance
- Drugs Dronedarone (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 14 Sep 2018 New trial record
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology